CIPA Life Sciences Conference
CIPA has long been where life sciences IP leaders compare notes on litigation, case law, and strategy. Patlytics is attending to share the benefits we're seeing across pharma teams putting AI to work.
Meet With Patlytics
Schedule a time to discuss how Patlytics can help your team.
From pre-litigation funding through UK, US, and EP case law updates, this year's program tracks a dispute’s full arc.
Patlytics will be there ready to discuss where AI fits in the picture, alongside the practitioners navigating that shift firsthand.
End-to-end lifecycle support
From prep and prosecution through invalidity, infringement, FTO and licensing — one platform across every stage.
Built for life sciences IP
Draw chemical structures, define Markush groups, and draft from biological sequences directly in the workspace with FDA Orange Book and Purple Book data built in.
Freedom-to-operate before launch
Search and analysis across US, EP, KR, JP, WO, TW, and CN filings, backed by a 145M+ patent database.
Will you be at CIPA Life Sciences Conference?
Schedule a time to meet with us during the event.
Vashe Kanesarajah is Managing Director for Europe at Patlytics, leading European operations from London after 20+ years in AI, IP, and strategy — most recently as VP of Strategy at Clarivate, where he sat on the IP division's executive leadership team overseeing portfolio strategy, acquisitions, and product across 30+ countries.
He’s worked across law firms, R&D organisations, and government IP offices in the US, Europe, the Middle East, and Asia, speaks regularly on patent intelligence and AI in patent practice, and holds a master's in intellectual property and a degree in mechanical engineering.